NASDAQ:APGE | Free Cash Flow | Apogee Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$55.57M
2025-12-31-$62.69M$62,000.00-$62.75M
2025-03-31-$48.48M$4.32M-$52.79M
2024-12-31-$67.71M-$1,000.00-$67.72M
2024-03-31-$31.64M$351,000.00-$31.99M
2023-12-31-$29.75M
2023-03-31-$10.56M
2022-12-31-$9.19M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$227.45M$5.15M-$232.6M
2024-12-31-$171.17M$1.15M-$172.33M
2023-12-31-$74.76M$167,000.00-$74.93M
2022-12-31-$16.43M